Inflammation, obesity and risk of hypertension: Shared pathways or independent risk factors

Journal of Human Hypertension

Volumn 25, Issue 2, 2011, Pages 71-72

  Engstrom G ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; FIBRINOGEN; INTERLEUKIN 6;

ADIPOSE TISSUE; ATHEROSCLEROSIS; BODY MASS; DISEASE MARKER; HUMAN; HYPERTENSION; INCIDENCE; INFLAMMATION; NOTE; OBESITY; PROGNOSIS; RISK FACTOR; SMOKING; WAIST CIRCUMFERENCE;

HUMANS; HYPERTENSION; INFLAMMATION; METABOLIC PHENOMENA; OBESITY; RISK FACTORS; SMOKING;

EID: 78651407326     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.92     Document Type: Note

References (15)

1. Bautista LE. Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence. J Hum Hypertens 2003; 17: 223-230.
2. Gillum RF, Mussolino ME. White blood cell count and hypertension incidence. The NHANES I Epidemio-logic Follow-up Study. J Clin Epidemiol 1994; 47: 911-919.
3. Engström G, Hedblad B, Berglund G, Janzon L, Lindgärde F. Plasma levels of complement C3 is associated with development of hypertension: a longi-tudinal cohort study. J Hum Hypertens 2007; 21: 276-282.
4. Sesso HD, Wang L, Buring JE, Ridker PM, Gaziano JM. Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women. Hypertension 2007; 49: 304-310.
5. Folsom AR, Peacock JM, Nieto FJ, Rosamond WD, Eigenbrodt ML, Davis CE et al. Plasma fibrinogen and incident hypertension in the Atherosclerosis Risk in Communities (ARIC) Study. J Hypertens 1998; 16: 1579-1583.
6. Engström G, Janzon L, Berglund G, Lind P, Stavenow L, Hedblad B et al. Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins. Arterioscler Thromb Vasc Biol 2002; 22: 2054-2058.
7. Duncan BB, Schmidt MI, Chambless LE, Folsom AR, Carpenter M, Heiss G Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults\the ARIC study. Atherosclerosis Risk in Communities. Obes Res 2000; 8: 279-286.
8. Engström G, Hedblad B, Stavenow L, Lind P, Janzon L, Lindgärde F Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes 2003; 52: 2097-2101.
9. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 2005; 184: 285-293.
10. Sarzani R, Bordicchia M, Marcucci P, Minardi D, Muzzonigro G, Dessì-Fulgheri P et al. Angiotensinogen promoter variants influence gene expression in human kidney and visceral adipose tissue. J Hum Hypertens 2010; 24: 213-219.
11. Lind P, Engström G, Stavenow L, Janzon L, Lindgärde F, Hedblad B. Risk of myocardial infarction and stroke in smokers is related to plasma levels of inflammation-sensitive proteins. Arterioscler Thromb Vasc Biol 2004; 24: 577-582.
12. Lee DH, Ha MH, Kim JR, Jacobs DR. Effects of smoking cessation on changes in blood pressure and incidence of hypertension. A four-year follow up study. Hypertension 2001; 37: 194-198.
13. Lakoski SG, Cushman M, Siscovick DS, Blumenthal RS, Palmas W, Burke G et al. The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). J Hum Hypertens 2011; 25: 73-79.
14. Rosner B, Spiegelman D, Willett WC. Correction of logistic regression relative risk estimates and confi-dence intervals for random within-person measure-ment error. Am J Epidemiol 1992; 136: 1400-1413.
15. Andersson N, Strandberg L, Nilsson S, Adamovic S, Karlsson MK, Ljunggren O et al. A variant near the interleukin-6 gene is associated with fat mass in Caucasian men. Int J Obes 2010; 34: 1011-1019.